280: ESMO highlights, Roivant's big deal, & biotech VC on the rise
The Readout Loud
00:00
Excitement for Subcutaneous Drug at ESMO Meeting
This chapter explores the potential of a subcutaneous version of a drug to increase access and convenience for patients. It discusses the benefits of self-administration at home using an auto injector pen but raises concerns about the lack of close monitoring. It also mentions the timeline for FDA filing, potential approval, and availability of the sub-Q version of the drug.
Transcript
Play full episode
